Episode 176: Oncologic Emergencies 101: Cytokine Release Syndrome
ONS member Theresa Latchford, RN, MS, AOCNS®, BMTCN®, clinical nurse specialist at Stanford Health Care in Palo Alto, CA, and member of the Silicon Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cytokine release syndrome and its associated immunotherapies. This episode is part of a new series about oncologic emergencies. We’ll add a link to future episodes in the show notes after the second episode next month.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by October 8, 2023. Theresa Latchford discloses receiving a speaker honoraria from Kite Gilead and Bristol Myers Squibb. The financial relationship has been mitigated. No other planners or faculty members have anything to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation.
Episode Notes
Check out these resources from today’s episode:
- Complete this evaluation for free NCPD.
- ONS Voice article: A Body of Evidence Helps Nurses Manage CAR T-Cell Therapy Toxicities
- ONS Voice article: Learn the Nursing Considerations for Cytokine Release Syndrome
- ONS Voice article: Nurses Help Patients Weather the Storm of CAR T-Cell Therapy
- ONS Voice article: Oncology Drug Reference Sheet: Tocilizumab
- Clinical Journal of Oncology Nursing article: Cytokine-Release Syndrome: Overview and Nursing Implications
- Clinical Journal of Oncology Nursing STAT sheet on cytokine release syndrome
- ONS clinical practice resource on cytokine release syndrome
- ONS course: Essentials in Oncologic Emergencies for the Advanced Practice Provider
- ONS video: Cytokine Release Syndrome
- BMT Infonet
- Leukemia and Lymphoma Society
- 2021 study on cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.